Live Oak Health Sciences LOGSX
At closeNov 6, 2026, 8:09 PM EST
Day range unavailable
- YTD
- +19.07%
- 1 year
- +22.94%
- Market cap
- 66.39M
- EPS (ttm)
- 1.20
- P/E ratio
- 23.33
- YTD return
- +19.07%
- 1-year return
- +22.94%
- Previous close
- 28.06
- 52-week range
- 22.82 – 28.74
2Y +5.41 (+23.89%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 21.83
- 200-day average
- 21.71
About Live Oak Health Sciences
The fund invests primarily in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. It will invest at least 80% of its net assets, under normal circumstances, in equity securities of health science companies. The fund invests primarily in common stocks of U.S. companies, but may, to a lesser extent, invest in equity REITs, common stocks of foreign companies and American Depositary Receipts ("ADRs") that meet the investment criteria of the fund.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on LOGSX — it syncs with the Stock Master app.